Annotation Detail for PELI3

Basic Information
Top
Pathway ID | Pathway Name |
---|
| Signaling in Immune system |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of PELI3 mRNA | increases expression | 20106945
|
D004958 |
Estradiol |
Estradiol results in increased expression of PELI3 mRNA | increases expression | 20106945
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.18 | 11473722 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.10 | 19861407 17289903 17018787 12948864 17261762 18497071 14630087 16675129 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
5.35 | 16111702 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
1.80 | 16924424 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
7.67 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
7.67 | 18566989 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.28 | 19486331 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.88 | 19279558 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
3.28 | 19148513 18566989 11473722 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
3.40 | 19224547 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.90 | 12639820 12168785 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
5.11 | 8708960 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
5.31 | 15720958 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
6.10 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
4.82 | 17088409 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.24 | 10903974 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
3.26 | 16627594 16393666 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
5.51 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.77 | 10903974 18776723 8314463 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
6.77 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
8.75 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
8.75 | 15610895 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
1.69 | 14659978 14716833 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
2.85 | 16891317 11807958 17203775 11408345 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
5.55 | 19453300 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.86 | 16801185 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.66 | 16810080 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
4.62 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
5.51 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.75 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
4.32 | 11399458 16427766 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
2.33 | 19401270 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.69 | 12371664 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
4.44 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.01 | 16740699 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.35 | 16882103 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
5.76 | 19048282 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
5.05 | 1336536 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
5.51 | 17120751 |
Pathway ID |
Pathway Name |
---|
REACT:6900 |
Signaling in Immune system |